Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: a 6-month, open-label, randomized, pilot trial

被引：0
|
作者：
Yoshiteru Takekita
Yosuke Koshikawa
Chiara Fabbri
Shiho Sakai
Naotaka Sunada
Ai Onohara
Keiichiro Nishida
Masafumi Yoshimura
Masaki Kato
Alessandro Serretti
Toshihiko Kinoshita
机构：
[1] University of Bologna,Department of Biomedical and NeuroMotor Sciences
[2] Kansai Medical University,Department of Neuropsychiatry
来源：
BMC Psychiatry | / 16卷
关键词：
Schizophrenia; Risperidone long-acting injection; Paliperidone palmitate; Cognitive function; Efficacy; Subjective well-being;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: a 6-month, open-label, randomized, pilot trial
    Takekita, Yoshiteru
    Koshikawa, Yosuke
    Fabbri, Chiara
    Sakai, Shiho
    Sunada, Naotaka
    Onohara, Ai
    Nishida, Keiichiro
    Yoshimura, Masafumi
    Kato, Masaki
    Serretti, Alessandro
    Kinoshita, Toshihiko
    BMC PSYCHIATRY, 2016, 16
  • [2] The Comparative Effects of Risperidone Long-Acting Injection and Paliperidone Palmitate on Social Functioning in Schizophrenia: A 6-Month, Open-Label, Randomized Controlled Pilot Trial
    Koshikawa, Yosuke
    Takekita, Yoshiteru
    Kato, Masaki
    Sakai, Shiho
    Onohara, Ai
    Sunada, Naotaka
    Nishida, Keiichiro
    Yoshimura, Masafumi
    Fabbri, Chiara
    Serretti, Alessandro
    Kinoshita, Toshihiko
    NEUROPSYCHOBIOLOGY, 2016, 73 (01) : 35 - 42
  • [3] The effects of risperidone long-acting injection versus paliperidone palmitate on cognitive and social function in schizophrenia - an open pilot randomised controlled trial
    Koshikawa, Y.
    Takekita, Y.
    Kato, M.
    Sakai, S.
    Onohara, A.
    Sunada, N.
    Nishida, K.
    Yoshimura, M.
    Fabbri, C.
    Serretti, A.
    Kinoshita, T.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S500 - S501
  • [4] A randomized trial of paliperidone palmitate and risperidone long-acting injectable in schizophrenia
    Fleischhacker, W. Wolfgang
    Gopal, Srihari
    Lane, Rosanne
    Gassmann-Mayer, Cristiana
    Lim, Pilar
    Hough, David
    Remmerie, Bart
    Eerdekens, Marielle
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 (01): : 107 - 118
  • [5] A comparative randomized, open-label, rater-blinded study of paliperidone palmitate and risperidone long-acting injectable therapy in patients with schizophrenia
    Li, H.
    Rui, Q.
    Ning, X.
    Xu, H.
    Gu, N.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 167 - 167
  • [6] Safety and efficacy of long-acting injectable risperidone in patients with schizophrenia spectrum disorders: A 6-month open-label trial in Asian patients
    Verma, Swapna
    Subramaniam, Mythily
    Abdin, Edimansyah
    Sim, Kang
    Su, Alex
    Lee, Nelson
    Chong, Siow Ann
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2010, 25 (03) : 230 - 235
  • [7] AN OPEN-LABEL, 6-MONTH OBSERVATIONAL STUDY OF PATIENTS WITH SCHIZOPHRENIA OR SCHIZOAFFECTIVE DISORDERS RECEIVING RISPERIDONE LONG ACTING INJECTION
    Hustig, Harry
    Newton, Richard
    Nyst, Phil
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2009, 43 : A56 - A56
  • [8] COST OF LONG-ACTING RISPERIDONE INJECTION VERSUS LONG-ACTING PALIPERIDONE PALMITATE IN PATIENTS WITH SCHIZOPHRENIA IN RUSSIA
    Omelyanovsky, V
    Avxentyeva, M.
    Ivakhnenko, O.
    Khailov, P.
    Tsfasman, F. M.
    Krysanov, I
    Zorin, N.
    VALUE IN HEALTH, 2012, 15 (07) : A338 - A338
  • [9] TOLERABILITY AND EFFICACY OF PALIPERIDONE PALMITATE VS. RISPERIDONE LONG-ACTING THERAPY IN SUBJECTS WITH RECENTLY DIAGNOSED SCHIZOPHRENIA
    Sliwa, Jennifer Kern
    Bossie, Cynthia
    Fu, Dong Jing
    Ma, Y. M.
    Alphs, L.
    SCHIZOPHRENIA BULLETIN, 2011, 37 : 310 - 310
  • [10] Effects of Continuing Oral Risperidone vs. Switching from Risperidone to Risperidone Long-Acting Injection on Cognitive Function in Stable Schizophrenia Patients: A Pilot Study
    Hori, Hikaru
    Katsuki, Asuka
    Atake, Kiyokazu
    Yoshimura, Reiji
    FRONTIERS IN PSYCHIATRY, 2018, 9
12345